Barclays analyst Lauren Lieberman raised the firm’s price target on Clorox to $113 from $108 and keeps an Underweight rating on the shares ahead of the Q1 results. Within the firm’s staples universe, the analyst continues to favor names that have greater visibility to volume growth, either through enhanced category exposure or idiosyncratic factors.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLX: